HighLife Medical Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 22
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $36.5M
Latest Deal Amount
  • Investors
  • 8

HighLife Medical General Information

Description

Developer of a novel transcatheter replacement system designed to help in the treatment of mitral regurgitation. The company's system targets optimal treatment outcomes as it can be delivered through a transseptal passage via the femoral vein in a reversible manner, and self-locates inside the native annulus, enabling physicians to reduce trauma to the patients while caring out severe heart surgery procedures.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 168 rue de Grenelle
  • 75007 Paris
  • France

HighLife Medical Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

HighLife Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 10-Jan-2019 $36.5M 0000 000.00 Completed Generating Revenue
3. Later Stage VC (Series A) 29-Jul-2017 000.00 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 26-Nov-2012 $5.39M $12.3M Completed Generating Revenue
1. Early Stage VC 09-Nov-2012 $6.93M $6.93M 000.00 Completed Generating Revenue
To view HighLife Medical’s complete valuation and funding history, request access »

HighLife Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
B Shares 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
A2 Shares 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
A Shares 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
A Shares 1,634,241 $0.011407 $2.93 $2.93 1x $2.93 3.19%
Ordinary 450,770 $0.011407 $2.93 $2.93 1x $2.93 0.88%
To view HighLife Medical’s complete cap table history, request access »

HighLife Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a novel transcatheter replacement system designed to help in the treatment of mitral regurgitation. The com
Therapeutic Devices
Paris, France
22 As of 2020
0000
00.00 0000-00-00
00000000000 0000

000000

ation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderi
00000000000 0000000
Eagan, MN
0000
000000000 - 0000

00000000

dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sin
00000000000 0000000
Hilden, Germany
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HighLife Medical Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cardia Angel-Backed Eagan, MN 0000 000000000 - 0000
00000000 000000000 Venture Capital-Backed Hilden, Germany 00 000.00 0000000000 0 000.00
0000000 0000000000 Venture Capital-Backed Kirkland, WA 00 00000 00000000000 00000
00000 000000000000 Venture Capital-Backed Newtown, PA 0 000.00 00000000000 000.00
0000000 Venture Capital-Backed Herzliya, Israel 00 000.00 00000000000 000.00
You’re viewing 5 of 11 competitors. Get the full list »

HighLife Medical Executive Team (2)

Name Title Board Seat Contact Info
Georg Börtlein Founder, Chief Executive Officer, President & Board Member
Martin Rothman Chief Medical Officer & Board Member
To view HighLife Medical’s complete executive team members history, request access »

HighLife Medical Board Members (8)

Name Representing Role Since
Anne Osdoit Sofinnova Partners Board Observer 000 0000
Antoine Papiernik Sofinnova Partners Board Member 000 0000
Casey Tansey US Venture Partners Board Member 000 0000
Jose Gordo Self Chairman of the Board 000 0000
Marc-André Marcotte Sectoral Asset Management Board Observer 000 0000
You’re viewing 5 of 8 board members. Get the full list »

HighLife Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HighLife Medical Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Andera Partners PE/Buyout Minority 000 0000 000000 0
Jose Gordo Angel (individual) Minority 000 0000 000000 0
Sectoral Asset Management Asset Manager Minority 000 0000 000000 0
US Venture Partners Venture Capital Minority 000 0000 000000 0
VI Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »